Drug Profile
Research programme: diabetes therapy - Avecho Biotechnology/Baker Heart Research Institute
Latest Information Update: 29 Dec 2020
Price :
$50
*
At a glance
- Originator Baker Medical Research Institute; Phosphagenics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 24 Aug 2005 Preclinical trials in Type-2 diabetes mellitus in Australia (unspecified route)